Sclerotherapy for the mucoceles of the anterior lingual salivary glands with pingyangmycin.

Abstract

Recurrence is very common if the mucoceles of the anterior lingual salivary glands (ALSGs) are treated by surgery due to its anatomic characteristics. Therefore, more effective and less invasive treatment methods are urgently required to be applied instead of surgery. In this study, 40 patients with the mucocele of the ALSGs received the intralesional injections of pingyangmycin, and the median number of injections per patient was 2.075 (range, 1-3). All cases completely recovered with no recurrence after follow-up of more than 16 months. The complications included the local swelling, pain, and ulceration following injection, and all these symptoms resolved 7-10 days after the injection. Taken together, sclerotherapy with pingyangmycin is an effective and safe treatment method for the mucocele of the ALSGs and may be the primary treatment modality.

• Authors: Y Cai, R Wang, S-F Yang, Y-F Zhao, J-H Zhao
• Journal: Oral diseases (Oral Dis) Vol. 20 Issue 5 Pg. 473-6 (Jul 2014) ISSN: 1601-0825 [Electronic] Denmark
• PMID: 23848975 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Chemical References

• Bleomycin
• bleomycetin

Topics

• Adolescent
• Adult
• Bleomycin (analogs & derivatives, therapeutic use)
• Child
• Child, Preschool
• Female
• Humans
• Male
• Mucocele (therapy)
• Salivary Gland Diseases (therapy)
• Salivary Glands
• Sclerotherapy (methods)